Items Tagged ‘#Individualizing Medicine 2017’

October 10th, 2017

#CIMCon17 day two explores how precision medicine can improve population health

By Sharon Rosen sharonhrosen

Sharing cutting-edge research, clinical practice insights and networking continued at the second day of Individualizing Medicine 2017: Advancing Care Through Genomics, a conference hosted by the Mayo Clinic Center for Individualized Medicine in Rochester, Minnesota. Empirical data critical to advancing genomic medicine Robert Green, M.D., started the morning sessions by acknowledging that there are still many who […]

View full entry

Tags: #CIMCon17, #direct-to-consumer genetic testing, #Dr. Rachel Tyndale, #Dr. Robert Green, #Empirical genomic data, #Genomic data, #genomic testing, #Home DNA tests, #Individualizing Medicine 2017, #medical resarch, #pharmacogenomics testing, #smoking cessation


October 5th, 2017

#CIMCon17: learn from experts moving genomic discoveries into patient care

By Sharon Rosen sharonhrosen

Mayo Clinic is a leader in moving important advancements in precision medicine from the laboratory into patient care, offering hope and healing. The Individualizing Medicine Conference: Advancing Care Through Genomics gives medical providers and scientists the opportunity to learn firsthand the newest ways genomic medicine is improving care for patients. The Mayo Clinic Center for […]

View full entry

Tags: #CIMCon17, #Consumer genomics, #Dr. David Ledbetter, #Dr. David Relman, #Dr. Judy Cho, #Dr. Rachel Tyndale, #Dr. Rob Knight, #Dr. Robert Green, #Dr. Stephanie Devaney, #Dr. William Gahl, #genomic testing, #Home DNA tests


October 3rd, 2017

Liquid biopsies: detecting and treating cancer sooner

By Sharon Rosen sharonhrosen

What if a blood test could discover cancer before a tumor first appears or before the first signs of cancer recurrence are seen by a radiology study? In fact, these types of blood tests, often called liquid biopsies, are already changing clinical care for patients with cancer. Researchers and physicians in Mayo Clinic Center for […]

View full entry

Tags: #blood tests, #cancer treatment, #cell-free DNA testing, #CIMCon17, #circulating tumor cells, #Dr. Minetta Liu, #Individualizing Medicine 2017, #liquid biopsies, Advanced Cancer, breast cancer, cancer, cancer screening


September 27th, 2017

A genetic approach to cancer treatment

By Sharon Rosen sharonhrosen

Article by Kristin Clift The medical community has historically defined and treated cancer based on where it is found in the body, such as the breast, lung or colon. So what has changed?  The FDA has recently started to approve treatments based on the genetic makeup of cancer rather than where the cancer is located. […]

View full entry

Tags: #cancer treatment, #CIMCon17, #DNA analysis, #Genetic Epidemiology and Risk Assessment Program, #Individualizing Medicine 2017, #targeted therapies, Advanced Cancer, cancer, center for individualized medicine, DNA Sequencing, Dr. Alexander Parker, Genetic Testing


September 25th, 2017

Study evaluates effectiveness of deep genomic profiling in clinical setting

By Colette Gallagher colettegallagher

Genomic profiling is used today for patients with advanced cancers to help develop new ways to diagnose and treat their disease and offer an individualized treatment plan. While gene panel testing is relatively commonplace, there are many barriers to using new and more sophisticated DNA technologies. According to Mitesh Borad, M.D., an oncologist at the […]

View full entry

Tags: #cancer treatment, #CIMCon17, #Dr. Mitesh Borad, #genetic profiling, #Individualizing Medicine 2017, #long-insert whole genome, #Nature scientific Reports, #targeted therapies, #whole transcriptome sequencing, Advanced Cancer, center for individualized medicine, mayo clinic


September 19th, 2017

How does a genomic tumor board impact patient care?

By Colette Gallagher colettegallagher

The outcomes from a Mayo Clinic study published in Oncotarget found value in having an established genomic tumor board, and using genomics for certain patients. The experience of the Genomic Tumor Board has promoted an evolution in the practice according to Alan Bryce, M.D., a Mayo Clinic oncologist, and co-first author on the study. “There […]

View full entry

Tags: #cancer treatment, #CIMCon17, #Dr. Jan Egan, #genetic testing fees, #Genomic analysis, #Genomic Tumor Board, #Individualizing Medicine 2017, #targeted therapies, Advanced Cancer, cancer, center for individualized medicine, Dr. Alan Bryce


September 6th, 2017

Mayo Clinic Individualizing Medicine Conference showcases MyCode Genomic Study leader

By Sharon Rosen sharonhrosen

How can we harness the power of genomics so physicians can easily access their patients’ genetic information to provide an individualized approach to preventing, screening, diagnosing and treating disease? This is a question many precision medicine researchers are addressing, including David Ledbetter, Ph.D., who is leading the MyCode Community Health Initiative. This innovate research effort […]

View full entry

Tags: #CIMCon17, #DNA sequencing tests, #Dr. David Ledbetter, #electronic medical record, #Genomic data, #Gesinger Health System, #Individualizing Medicine 2017, #MyCode Genomic Study, center for individualized medicine, electronic health record, mayo clinic, medical research


August 31st, 2017

The Grand Challenge: using supercomputers to speed diagnosis and treatment

By Sharon Rosen sharonhrosen

If you are a cancer patient who has exhausted all standard treatment options, a one day turnaround of your DNA testing results could make a big difference in your search for new, individualized treatment options. Mayo Clinic envisions just that: using supercomputers that are so fast and efficient they can interpret your DNA sequence in […]

View full entry

Tags: #big data challenges, #CIMCon17, #Dr. Eric Wieben, #Dr. Timothy Nelson, #Dr. Timothy Olson, #genetic data analysis, #Genomic data, #Individualizing Medicine 2017, #Mathieu Wiepert, Big Data, center for individualized medicine, Center for Regenerative Medicine


August 29th, 2017

Exploring ethical issues to improve reproductive health

By Sharon Rosen sharonhrosen

New genomic technologies offer great promise for better diagnostic tests and treatments for many conditions. But they also pose new ethical questions – ones physicians and patients must address when making decisions about medical care. For example, genetic tests can determine if a couple is at risk of having a child with a genetic condition. […]

View full entry

Tags: #Center for Individualized Medicine Bioethics Program, #CIMCon17, #developmental pediatric services, #Down syndrome, #Dr. Megan Allyse, #Genetic diseases, #genetic disorders, #Genomic analysis, #Individualizing Medicine 2017, #Klinefelter syndrome, #perinatal testing, #prenatal genetic testing


August 23rd, 2017

Gerstner Awardees explore individualized treatments for obesity, rare form of leukemia

By Sharon Rosen sharonhrosen

Precision medicine research has shown that one size does not fit all when it comes to medical care. Early career investigators can bring new ideas and perspectives to the search for treatments tailored to a patient’s unique needs. These are the goals of Andres Acosta, M.D., Ph.D., and Mrinal Patnaik, M.B.B.S. – this year’s recipients […]

View full entry

Tags: #chronic myelomonocytic leukemia, #CIMCon17, #Dr. Andres Acosta, #Dr. Mrinal Patnaik, #Gerstner Family Career Development Award, #Individualizing Medicine 2017, #leukemia, #NRAS gene, #obesity, #rare diseases, #weight loss, center for individualized medicine


Contact Us · Privacy Policy